More than 2000 drugs now in cancer immunotherapy race – Reuters
|
More than 2000 drugs now in cancer immunotherapy race
Reuters Roche Chief Executive Severin Schwan is convinced the mass rush into the hot new field of immunotherapy will lead to multiple disappointments. As the world’s biggest cancer drug company, the Swiss group expects to emerge among a handful of winners but … |
Endpoints News |
Taking on gamma delta T cells, bluebird pays $16M for TC BioPharm’s tumor invading tech platform
Endpoints News Gene therapy pioneer bluebird bio is teaming up with Scotland’s TC BioPharm to get its hands on an experimental program involving an emerging immunotherapy platform: CAR-engineered gamma delta T cells. As part of the deal, bluebird $BLUE is paying TC … bluebird bio (BLUE) Reports Strategic Collaboration with TC BioPharm to Research and Develop Gamma Delta CAR T …StreetInsider.com Life sciences group TC BioPharm secures $16m US tie-up to develop new cancer treatmentsinsider.co.uk TC BioPharm teams up with bluebird bio to develop gamma delta CAR TsSeeking Alpha NB Herard –Market Exclusive all 5 news articles » |